We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Viruses Modified to Combat Harmful ‘Biofilms”

By Biotechdaily staff writers
Posted on 26 Jul 2007
In one of the first potential applications of synthetic biology, an emerging field that aims to design and build useful biomolecular systems, researchers are engineering viruses to attack and destroy the surface "biofilms” that harbor harmful bacteria in the body and on industrial and medical devices.

The researchers, from Massachusetts Institute of Technology (MIT: Cambridge, MA, USA) and Boston University (BU; Boston, MA, USA), have already successfully demonstrated one such virus, and due to a "plug and play” library of "parts,” believe that many more could be custom-designed to target different species or strains of bacteria.

The study, reported in the July 3, 2007 issue of the journal Proceedings of the [U.S.] National Academy of Sciences, helps push synthetic biology from a conceptual science
to one that has proven practical applications. More...
"Our results show we can do simple things with synthetic biology that have potentially useful results,” stated first author Dr. Timothy Lu, a doctoral student in the Harvard University (Cambridge, MA, USA)-MIT Division of Health Sciences and Technology.

Bacterial biofilms can form nearly anywhere, even on teeth if they are not brushed for a day or two. When they accumulate in hard-to-reach areas such as the insides of food processing machines or medical catheters, however, they become persistent sources of infection.

These bacteria excrete a variety of proteins, polysaccharides, and nucleic acids that combined with other accumulating materials form an extracellular matrix, or in Dr. Lu's words, a "slimy layer,” that encloses the bacteria. Conventional remedies such as antibiotics are not as effective on these bacterial biofilms as they are on free-floating bacteria. In some instances, antibiotics even encourage bacterial biofilms to form.

Dr. Lu and senior author Dr. James Collins, professor of biomedical engineering at BU, aim to eradicate these biofilms using bacteriophage, tiny viruses that attack bacteria. Phages have long been used in Eastern Europe and Russia to treat infection.

For a phage to be effective against a biofilm, it must both attack the strain of bacteria in the film and degrade the film itself. Recently, a different group of researchers discovered several phages in sewage that meet both criteria because, among other things, they carry enzymes capable of degrading a biofilm's extracellular matrix.

This finding led the researchers to try modfying phages to carry enzymes with similar capabilities. The reason for this is that finding a good naturally occurring combination for a given industrial or medical problem is difficult. In addition, "people don't want to dig through sewage to find these phages,” noted Dr. Lu.

Therefore, Drs. Collins and Lu defined a modular system that allows engineers to devise phages to target specific biofilms. As a proof of concept, they used their strategy to modify T7, an Escherichia coli-specific phage, to express dispersin B (DspB), an enzyme known to disperse a variety of biofilms.

To evaluate the engineered T7 phage, the team cultivated E. coli biofilms on plastic pegs. The investigators discovered that their engineered phage eliminated 99.997% of the bacterial biofilm cells, an improvement by two orders of magnitude over the phage's nonengineered cousin.

The team's modular approach can be thought of as a "plug and play” library, according to Dr. Collins. "The library could contain different phages that target different species or strains of bacteria, each constructed using related design principles to express different enzymes.” Creating such a library may soon be possible with new technologies for synthesizing genes quickly and inexpensively. "We hope in a few years, it will be easy to create libraries of phage that we know have a good chance of working a priori because we know so much about their inner workings,” said Dr. Lu.

Synthetic biology also makes it possible to control the timing of when a gene is expressed in an organism. For instance, Dr. Lu inserted the DspB genes into a precise location in the T7 genome so that the phage would strongly express it during infection rather than before or after. Such control was possible because T7 was very well characterized by other researchers, such as MIT synthetic biologist Dr. Drew Endy, an assistant professor of biological engineering.

Although phages are not approved for use in humans in the United States, recently the U.S. Food and Drug Administration (FDA) approved a phage cocktail to treat Listeria monocytogenes on lunchmeat. This makes certain applications, such as cleaning products that include phages to eradicate slime in food-processing plants, more immediately promising. Another potential application: phage-containing drugs for use in livestock in exchange for or in combination with antibiotics.


Related Links:
Massachusetts Institute of Technology
Boston University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Urine Analyzer
respons® UDS100
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.